Health
Human Trials Begin for Candidate Vaccine Against Lassa Fever with Global Health Partners Launching Plans in Nigeria
A candidate vaccine targeting Lassa fever has commenced human trials in the UK, offering optimism for controlling a disease that triggers consistent outbreaks in Nigeria and West Africa. This announcement was made during an interview featuring global health officials invested in the vaccine's development.